Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Valneva Se ADR (VALN)

Valneva Se ADR (VALN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Valneva Se ADR lot Saint-Joseph Bureaux Convergence Bat. A 12 ter Quai Perrache Lyon I0 69002 FRA

www.valneva.com Employees: 674 P: 33-2-28-07-37-10

Sector:

Medical

Description:

Valneva SE is a specialty vaccine company. It is focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva SE is based in Saint-Herblain, France.

Key Statistics

Overview:

Market Capitalization, $K 533,002
Enterprise Value, $K 611,652
Shares Outstanding, K 86,107
Float, K 73,268
% Float 85.09%
Short Interest, K 174
Short Float 0.20%
Days to Cover 12.71
Short Volume Ratio 0.28
% of Insider Shareholders 14.91%
% of Institutional Shareholders 11.39%

Financials:

Annual Sales, $ 197,610 K
Annual Net Income, $ -130,330 K
Last Quarter Sales, $ 55,520 K
Last Quarter Net Income, $ -58,230 K
EBIT, $ -6,280 K
EBITDA, $ -68,230 K

Growth:

1-Year Return -14.05%
3-Year Return -44.23%
5-Year Return 0.00%
5-Year Revenue Growth 56.81%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.68 on 03/17/26
Next Earnings Date 05/06/26
Earnings Per Share ttm -1.58
EPS Growth vs. Prev Qtr -11.48%
EPS Growth vs. Prev Year -25.93%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

VALN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -76.81%
Return-on-Assets % -26.33%
Profit Margin % -65.95%
Debt/Equity 1.69
Price/Sales 2.69
Price/Cash Flow N/A
Price/Book 4.42
Book Value/Share 1.39
Interest Coverage -1.72
60-Month Beta 1.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.